Skip to content

Drive Awareness

Opportunity

Knowledge of clinical trials as a treatment option may be limited or lacking among patients, especially underrepresented populations.  The use of multiple channels, such as community partners, social media, or physicians, to raise awareness about clinical trials allows the flow of information on this topic to patients who may not otherwise be aware of or consider clinical trial participation in order to support improved recruitment.

Considerations to Help Action the Opportunity

  • Develop a cohesive strategy for use of information channels to increase awareness and education around clinical research and clinical trial opportunities 
  • Co-create tools and informational assets (resources) for the channels with the intended users (e.g., patients, care partners, healthcare providers). Potential examples include materials to support clinical trial conversations, digital media in systems already used by patients (e.g., medical record systems, social media, etc.), materials / forums for use in community settings, etc.  
  • Partner with trusted sources of information for the patient, such as healthcare providers, community groups, and patient organizations, etc. to support provision of information and conversations with patients that are relevant and seek feedback to make meaningful adjustments

Value and Potential Benefits

  • Increases awareness of clinical trials
  • Encourages patients to have conversations with their health care providers about clinical trials as a treatment option to help identify clinical trials they can participate in 
  • Improves diversity and inclusion by engaging with patient populations that are previously underrepresented in our clinical trials
  • Improves retention, as patients may be better informed ahead of clinical trial participation and therefore have more time to make an informed decision (e.g., fewer unknowns or surprises for the patient)

Related Blog Posts

Redesigning Clinical Trials Using Artificial Intelligence

While tech evangelists often tout artificial intelligence (AI) as healthcare’s silver bullet, the reality in clinical trials is more complex. Adoption has been cautious, shaped as much by concerns around trust and governance as by technical hurdles. Still, beneath the surface, methodical innovation is gaining momentum. AI is beginning to reshape how trials are designed,…

How Pandemic-Era Ingenuity Fuels the Future of Clinical Trials

It’s hard to believe that just five years ago, the clinical research industry found itself scrambling to adapt overnight. The COVID-19 pandemic ground global health systems to a halt and forced us all to move faster and more collaboratively than ever before. Read the full article by Allison Cuff Shimooka from The Medicine Maker here.

Science is Moving—Clinical Trials Must Catch Up

Clinical research has never been more capable of reaching new frontiers. The science is here. The technology is here. But the approach to trial design and execution hasn’t kept pace. The clinical research ecosystem proceeds cautiously for good reasons—patient safety chief among them. But too often, we’re held back by fixed mindsets and outdated processes.…